| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35.1M | -2.0% | -1.0% |
| Cost of Revenue | $17.7M | +2.8% | +3.0% |
| Gross Profit | $17.4M | -6.3% | -4.7% |
| R&D Expense | $4.9M | -4.9% | -12.7% |
| SG&A Expense | $9.8M | +4.3% | +8.0% |
| Operating Income | -$2.3M | +78.2% | -883.7% |
| Pre-tax Income | -$2.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.5M | +1.5% | +56.9% |
| Accounts Receivable | $12.3M | +0.5% | -2.7% |
| Current Assets | $152.6M | +0.2% | +10.2% |
| Total Assets | $186.8M | -0.2% | +6.0% |
| Current Liabilities | $44.4M | -8.3% | -8.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.9M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$2.8M | — | — |
| Financing Cash Flow | -$1.6M | — | — |
| Free Cash Flow | $17.9M | — | — |
| +77.1% |
| -560.8% |
| Income Tax | $154K | +123.3% | -94.2% |
| Net Income | -$2.3M | +73.7% | -5.3% |
| EPS (Basic) | -$0.03 | +70.0% | -50.0% |
| EPS (Diluted) | -$0.03 | +70.0% | -50.0% |
| $51.2M |
| -7.5% |
| -9.1% |
| Stockholders' Equity | $135.7M | +2.9% | +13.1% |